Skip to main content
Bulletin of the National Research Centre
Fig. 2 | Bulletin of the National Research Centre

Fig. 2

From: Impact of highly active antiretroviral drug therapy (HAART) on biochemical, hematologic, atherogenic and anthropometric profiles of human immunodeficiency virus patients at a tertiary hospital in Owo, Nigeria

Fig. 2

a Cholesterol/HDL-c ratio of age-matched HIV-positive patients, HIV patients after a year on HAART, and HIV-negative subjects. ***p < 0.001 versus HIV-positive and HIV-negative; #p > 0.05 versus HIV-positive. Cholesterol/HDL-c ratio in HIV-positive patients was not significantly different from values for normal subjects but the ratio was skewed in HIV-positive patients on HAART; b LDL/HDL-c ratio of age-matched HIV-positive patients, HIV patients after a year of HAART, and HIV-negative subjects. ***p < 0.001 versus HIV-positive and HIV-negative; #p > 0.05 versus HIV-positive. LDL/HDL-c ratios were similar in HIV-positive patients and normal subjects but skewed in HIV-positive patients on HAART; c Atherogenic index of plasma (AIP) of HIV-positive patients, HIV patients after a year of HAART, and HIV-negative subjects. Each value is significantly different from the others (p < 0.05). Values indicated a lower cardiovascular risk for HIV-positive and HIV-negative groups

Back to article page